| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000024343 |
| Receipt No. | R000027832 |
| Official scientific title of the study | Imaging for Structural and Functional Changes of the Heart after Transcatheter Aortic Valve Implantation for Aortic Stenosis |
| Date of disclosure of the study information | 2016/10/08 |
| Last modified on | 2017/07/06 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Imaging for Structural and Functional Changes of the Heart after Transcatheter Aortic Valve Implantation for Aortic Stenosis | |
| Title of the study (Brief title) | Imaging-TAVI Study | |
| Region |
|
|
| Condition | ||
| Condition | Aortic stenosis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose of this study is to investigate the relationship between structural and functional changes of the heart after Transcatheter aortic valve implantation for aortic stenosis |
| Basic objectives2 | Others |
| Basic objectives -Others | Structural and functional changes of the heart after Transcatheter aortic valve implantation for aortic stenosis is assessed by perfusion CT and MRI |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | (1)Myocardial blood flow measured by perfusion CT |
| Key secondary outcomes | (2)Myocardial hypertrophy,fibrosis and edema measured by MRI
(3)General blood examination date,Rho-kinase activity (4)Remained angina (5)Ventricular function measured by cardiac echo (6)Left ventricular hypertrophy measured by ECG (7)Cognitive function measured by MMSE and Logical Memory (8)Leaflet thrombosis in bioprosthetic aortic valves (9)Mortality (10)Relationship between myocardial dysfunction and Rho-kinase |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | expanded access |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | Structural and functional changes of the heart is assessed by perfusion CT in three times | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who are applicate of transcatheter aortic valve implantation in aortic stenosis | |||
| Key exclusion criteria | (1)Coronary stenosis is over 50%
(2)EF is under 50% (3)Severe renal failure (4)Severe adenosine allergy |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroaki Shimokawa |
| Organization | Took University Hospital |
| Division name | Department of Cardiovascular Medicine |
| Address | 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574 Japan |
| TEL | +81-22-717-7153 |
| shimo@cardio.med.tohoku.ac.jp | |
| Public contact | |
| Name of contact person | Yasuharu Matsumoto |
| Organization | Took University Hospital |
| Division name | Department of Cardiovascular Medicine |
| Address | 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574 Japan |
| TEL | +81-22-717-7153 |
| Homepage URL | |
| matsumoto@cardio.med.tohoku.ac.jp | |
| Sponsor | |
| Institute | Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Mitsui Sumitomo Insurance Welfare Foundation |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027832 |